Showing results (3671-3680 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|September 11, 2008
Radiometal targeted tumor diagnosis and therapy with peptide hormonesD Zwanziger, A G Beck-SickingerCurrent Pharmaceutical Design|September 11, 2008
Cell penetrating peptides for in vivo molecular imaging applicationsVeerle Kersemans, Ken Kersemans, Bart CornelissenCurrent Pharmaceutical Design|September 11, 2008
Peptide nucleic acids (PNAs) as diagnostic devices for genetic and cytogenetic analysisFranck Pellestor, Petra Paulasova, Samir HamamahCurrent Pharmaceutical Design|September 11, 2008
Candidate circulating biomarkers for the cardiovascular disease continuumOlena Dotsenko, Julia Chackathayil, Jeetesh V Patel, et al.Current Pharmaceutical Design|September 11, 2008
Conus venoms - a rich source of peptide-based therapeuticsTiffany S Han, Russell W Teichert, Baldomero M Olivera, et al.Current Pharmaceutical Design|September 11, 2008
Peptides targeting voltage-gated calcium channelsRaymond S Norton, Stefan I McDonoughCurrent Pharmaceutical Design|September 17, 2016
Multiple Sclerosis, Gut Microbiota and Permeability: Role of Tryptophan Catabolites, Depression and the Driving Down of Local MelatoninMoses Rodriguez, Bharath Wootla, George AndersonCurrent Pharmaceutical Design|September 17, 2016
The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric DisordersEmily G Severance, Dag Tveiten, Lief H Lindström, et al.Current Pharmaceutical Design|September 17, 2016
The Role of Microbiota and Intestinal Permeability in the Pathophysiology of Autoimmune and Neuroimmune Processes with an Emphasis on Inflammatory Bowel Disease Type 1 Diabetes and Chronic Fatigue SyndromeGerwyn Morris, Michael Berk, André F Carvalho, et al.Current Pharmaceutical Design|June 24, 2017
Application of Alphaviral Vectors for Immunomodulation in Cancer TherapyAnna Zajakina, Karina Spunde, Kenneth LundstromPageof 1,008